Cargando…

A Case Report of Posterior Reversible Encephalopathy Syndrome (PRES) in a Nonsevere Case of COVID-19

Posterior reversible encephalopathy syndrome (PRES) is a rare complication that the exact pathophysiological mechanism of which is still unclear. PRES most often occurs in connection with severe hypertension and autoimmune diseases. It can also appear during chemotherapy or immunosuppressive treatme...

Descripción completa

Detalles Bibliográficos
Autores principales: Cisowska-Adamiak, Małgorzata, Sakwińska, Katarzyna, Szymkuć-Bukowska, Iwona, Goclik, Anna, Lunitz, Iwona, Mackiewicz-Milewska, Magdalena
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9313183/
https://www.ncbi.nlm.nih.gov/pubmed/35884722
http://dx.doi.org/10.3390/brainsci12070915
_version_ 1784754017063141376
author Cisowska-Adamiak, Małgorzata
Sakwińska, Katarzyna
Szymkuć-Bukowska, Iwona
Goclik, Anna
Lunitz, Iwona
Mackiewicz-Milewska, Magdalena
author_facet Cisowska-Adamiak, Małgorzata
Sakwińska, Katarzyna
Szymkuć-Bukowska, Iwona
Goclik, Anna
Lunitz, Iwona
Mackiewicz-Milewska, Magdalena
author_sort Cisowska-Adamiak, Małgorzata
collection PubMed
description Posterior reversible encephalopathy syndrome (PRES) is a rare complication that the exact pathophysiological mechanism of which is still unclear. PRES most often occurs in connection with severe hypertension and autoimmune diseases. It can also appear during chemotherapy or immunosuppressive treatment. A 38-year-old woman with a negative medical history was admitted to the local hospital due to loss of consciousness accompanied by seizures and high values of blood pressure, and a PCR test for COVID-19 was positive. The patient’s condition was preceded by weakness, wet cough, runny nose, and low-grade fever for three days. Due to the conducted diagnostics after negative CT scans and angio CT studies, an MRI of the head with contrast was performed, where changes characteristic of PRES syndrome were found. During the hospitalization, the patient did not require invasive ventilation and did not receive antiviral drugs or tocilizumab as a result of treatment for her high blood pressure values, and after establishing the diagnosis, the patient was discharged home with a significant improvement in her well-being. In the literature, there are discussions as to whether COVID-19 predisposes patients to PRES. Isolated cases have been described, but its frequency is not yet established. Case reports in the literature appear to be specifically associated with a severe course of the disease, unlike in our patient. Even with a mild course of COVID, the diagnosis of PRES should be taken into account in patients with seizures, visual disturbances, or other focal neurological deficits.
format Online
Article
Text
id pubmed-9313183
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-93131832022-07-26 A Case Report of Posterior Reversible Encephalopathy Syndrome (PRES) in a Nonsevere Case of COVID-19 Cisowska-Adamiak, Małgorzata Sakwińska, Katarzyna Szymkuć-Bukowska, Iwona Goclik, Anna Lunitz, Iwona Mackiewicz-Milewska, Magdalena Brain Sci Case Report Posterior reversible encephalopathy syndrome (PRES) is a rare complication that the exact pathophysiological mechanism of which is still unclear. PRES most often occurs in connection with severe hypertension and autoimmune diseases. It can also appear during chemotherapy or immunosuppressive treatment. A 38-year-old woman with a negative medical history was admitted to the local hospital due to loss of consciousness accompanied by seizures and high values of blood pressure, and a PCR test for COVID-19 was positive. The patient’s condition was preceded by weakness, wet cough, runny nose, and low-grade fever for three days. Due to the conducted diagnostics after negative CT scans and angio CT studies, an MRI of the head with contrast was performed, where changes characteristic of PRES syndrome were found. During the hospitalization, the patient did not require invasive ventilation and did not receive antiviral drugs or tocilizumab as a result of treatment for her high blood pressure values, and after establishing the diagnosis, the patient was discharged home with a significant improvement in her well-being. In the literature, there are discussions as to whether COVID-19 predisposes patients to PRES. Isolated cases have been described, but its frequency is not yet established. Case reports in the literature appear to be specifically associated with a severe course of the disease, unlike in our patient. Even with a mild course of COVID, the diagnosis of PRES should be taken into account in patients with seizures, visual disturbances, or other focal neurological deficits. MDPI 2022-07-13 /pmc/articles/PMC9313183/ /pubmed/35884722 http://dx.doi.org/10.3390/brainsci12070915 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Case Report
Cisowska-Adamiak, Małgorzata
Sakwińska, Katarzyna
Szymkuć-Bukowska, Iwona
Goclik, Anna
Lunitz, Iwona
Mackiewicz-Milewska, Magdalena
A Case Report of Posterior Reversible Encephalopathy Syndrome (PRES) in a Nonsevere Case of COVID-19
title A Case Report of Posterior Reversible Encephalopathy Syndrome (PRES) in a Nonsevere Case of COVID-19
title_full A Case Report of Posterior Reversible Encephalopathy Syndrome (PRES) in a Nonsevere Case of COVID-19
title_fullStr A Case Report of Posterior Reversible Encephalopathy Syndrome (PRES) in a Nonsevere Case of COVID-19
title_full_unstemmed A Case Report of Posterior Reversible Encephalopathy Syndrome (PRES) in a Nonsevere Case of COVID-19
title_short A Case Report of Posterior Reversible Encephalopathy Syndrome (PRES) in a Nonsevere Case of COVID-19
title_sort case report of posterior reversible encephalopathy syndrome (pres) in a nonsevere case of covid-19
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9313183/
https://www.ncbi.nlm.nih.gov/pubmed/35884722
http://dx.doi.org/10.3390/brainsci12070915
work_keys_str_mv AT cisowskaadamiakmałgorzata acasereportofposteriorreversibleencephalopathysyndromepresinanonseverecaseofcovid19
AT sakwinskakatarzyna acasereportofposteriorreversibleencephalopathysyndromepresinanonseverecaseofcovid19
AT szymkucbukowskaiwona acasereportofposteriorreversibleencephalopathysyndromepresinanonseverecaseofcovid19
AT goclikanna acasereportofposteriorreversibleencephalopathysyndromepresinanonseverecaseofcovid19
AT lunitziwona acasereportofposteriorreversibleencephalopathysyndromepresinanonseverecaseofcovid19
AT mackiewiczmilewskamagdalena acasereportofposteriorreversibleencephalopathysyndromepresinanonseverecaseofcovid19
AT cisowskaadamiakmałgorzata casereportofposteriorreversibleencephalopathysyndromepresinanonseverecaseofcovid19
AT sakwinskakatarzyna casereportofposteriorreversibleencephalopathysyndromepresinanonseverecaseofcovid19
AT szymkucbukowskaiwona casereportofposteriorreversibleencephalopathysyndromepresinanonseverecaseofcovid19
AT goclikanna casereportofposteriorreversibleencephalopathysyndromepresinanonseverecaseofcovid19
AT lunitziwona casereportofposteriorreversibleencephalopathysyndromepresinanonseverecaseofcovid19
AT mackiewiczmilewskamagdalena casereportofposteriorreversibleencephalopathysyndromepresinanonseverecaseofcovid19